- 25% of FDA-approved AI-enabled medical devices lacked clinical performance studies at approval.
- Retrospective designs were the most common clinical study type.
- Discriminatory performance metrics were inconsistently reported.
- Most devices were intended for radiology.
- 97.1% of devices were approved via the 510(k) pathway.
Source: JAMA Network Open
